undamentalytics Newsletter
Sign in

Fortrea Holdings Inc. revenue

Fortrea Holdings Inc.'s revenue was $2.72bn in fiscal 2025, up 1.0% on the year before. Since fiscal 2021 ($3.06bn) it has grown at a compound -2.9% a year. Over the last twelve months it was $2.67bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3,0582,8372,8432,6962,7232,667
Growth on the year before—−7.2%+0.2%−5.1%+1.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
North America $1.3B 47.4% ▲ 1.6%
Europe $852M 31.3% ▲ 6.5%
Other Geographical Areas $582M 21.4% ▼ 7.1%

From Fortrea Holdings Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Fortrea Holdings Inc. $2.67bn -3.4% 0.4%
Bio-rad Laboratories, Inc. $2.59bn 1.4% -2.2%
Medpace Holdings, Inc. $2.84bn 20.4% 16.8%
Qiagen N.V. $2.09bn 5.7% 17.1%
Bruker Corp $3.50bn 1.6% 8.8%
Charles River Laboratories $4.00bn -0.7% -1.5%

Compare with peers

Head to head: BIO vs FTREFTRE vs MEDPFTRE vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Fortrea Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Fortrea Holdings Inc.